Adult T-Cell Leukemia/Lymphoma
- 93 Downloads
Adult T-cell leukemia/lymphoma (ATLL) is a peripheral T-cell neoplasm most often composed of highly pleomorphic lymphoid cells. The disease is usually widely disseminated and is caused by the human retrovirus known as human T-cell leukemia virus type 1 (HTLV-1)(Ohshima et al. 2017).
References and Further Reading
- Bunn, P. A., Jr., Schechter, G. P., Jaffe, E., et al. (1983). Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. The New England Journal of Medicine, 309(5), 257–264.
- Fukushima, T., Miyazaki, Y., Honda, S., et al. (2005). Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma. Leukemia, 19(5), 829–834.
- Itoyama, A., Chaganti, R. S. K., Yamada, Y., et al. (2001). Cytogenetic analysis and clinical significance in adult T-cell leukemia/lymphoma: A study of 50 cases from the human T-cell leukemia virus type-1 endemic area, Nagasaki. Blood, 97(11), 3612–3620.
- Jaffe, E. S., Blattner, W. A., Blayney, D. W., et al. (1984). The pathologic spectrum of adult T-cell leukemia/lymphoma in the United States. The American Journal of Surgical Pathology, 8, 263–275.
- Levine, P. H., Manns, A., Jaffe, E. S., et al. (1994). The effect of ethnic differences on the pattern of HTLV-I-associated T-cell leukemia/lymphoma (HATL) in the United States. International Journal of Cancer, 56(2), 177–181.
- Ohshima, K., Suzumiya, J., Sato, K., et al. (1999). Survival of patients with HTLV-I-associated lymph node lesions. The Journal of Pathology, 189(4), 539–545.
- Ohshima, K., Jaffe, E.S., & Yoshino, T. (2017). Adult T-cell leukaemia/lymphoma. In S. H. Swerdlow, E. Campo, N. L. Harris, et al. (Eds.), WHO classification of tumours of haematopoietic and lymphoid tissues (Rev. 4th ed., pp. 363–367). Lyon: IARC.
- Shimoyama, M. (1999). Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984–87). British Journal of Haematology, 79(3), 428–437.
- Tajima, K. (1999). The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: Estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group. International Journal of Cancer, 45(2), 237–243.
- Takasaki, Y., Iwanaga, M., Imaizumi, Y., et al. (2010). Long-term study of indolent adult T-cell leukemia-lymphoma. Blood, 115(22), 4337–4343.
- Tsukasaki, K., et al. (2007). VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. Journal of Clinical Oncology, 25(34), 5458–5464.
- Tsukasaki, K., Hermine, O., Bazarbachi, A., et al. (2009). Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: A proposal from an international consensus meeting. Journal of Clinical Oncology, 27(3), 453–459.
- Yamaguchi, T., Ohshima, K., Karube, K., et al. (2005). Clinicopathological features of cutaneous lesions of adult T-cell leukaemia/lymphoma. The British Journal of Dermatology, 152(1), 76–81.